|
|
||||||||
1
* Molecular Neurobiology Branch, NIDA-IRP, National Institutes of Health, and
Departments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
1Correspondence: Molecular Neurobiology Branch, NIDA-IRP, National Institutes of Health, 5500 Nathan Shock Dr., Baltmore, MD 21224, USA.
Analyses of mutation effects can aid in understanding how large proteins act. The dopamine transporter (DAT) mediates complex actions in recognizing cocaine and in recognizing and translocating dopamine, sodium, and chloride. DAT proline residues, especially those in transmembrane (TM) domains, are good candidates for involvement in these DAT actions. We now report production of mutants substituting alanine and/or glycine residues for 16 prolines located in or near putative DAT TM domains. We examine effects of these modifications on DAT expression, dopamine uptake, and cocaine analog binding. Mutants in prolines located in five DAT TM domains and four connecting loops alter apparent DAT membrane targeting. Five mutations decrease dopamine affinities more than threefold without significantly decreasing cocaine analog affinities. One decreases cocaine analog affinity without decreasing dopamine affinity. Two mutations decrease affinities for both dopamine and cocaine analog. P101 is especially implicated in dopamine uptake. Alanine substitution for this proline yields dopamine Vmax values of less than 3% of wild-type values despite dopamine affinities more than fourfold higher than wild-type and normal Na+ and Cl- dependence. These DAT proline mutants identify DAT regions likely for dopamine translocation and for recognition of dopamine and cocaine.Lin, Z., Itokawa, M., Uhl, G. R. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.
Key Words: affinity translocation ion gradients turnover rate plasma membrane targeting
This article has been cited by other articles:
![]() |
N. Hussainzada, A. Khandewal, and P. W. Swaan Conformational Flexibility of Helix VI Is Essential for Substrate Permeation of the Human Apical Sodium-Dependent Bile Acid Transporter Mol. Pharmacol., February 1, 2008; 73(2): 305 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kinclova-Zimmermannova, M. Zavrel, and H. Sychrova Identification of Conserved Prolyl Residue Important for Transport Activity and the Substrate Specificity Range of Yeast Plasma Membrane Na+/H+ Antiporters J. Biol. Chem., August 26, 2005; 280(34): 30638 - 30647. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Martin and K. Kirk The Malaria Parasite's Chloroquine Resistance Transporter is a Member of the Drug/Metabolite Transporter Superfamily Mol. Biol. Evol., October 1, 2004; 21(10): 1938 - 1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Koike, G. Conseil, E. M. Leslie, R. G. Deeley, and S. P. C. Cole Identification of Proline Residues in the Core Cytoplasmic and Transmembrane Regions of Multidrug Resistance Protein 1 (MRP1/ABCC1) Important for Transport Function, Substrate Specificity, and Nucleotide Interactions J. Biol. Chem., March 26, 2004; 279(13): 12325 - 12336. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gaffaney and R. A. Vaughan Uptake Inhibitors but not Substrates Induce Protease Resistance in Extracellular Loop Two of the Dopamine Transporter Mol. Pharmacol., March 1, 2004; 65(3): 692 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Loland, C. Granas, J. A. Javitch, and U. Gether Identification of Intracellular Residues in the Dopamine Transporter Critical for Regulation of Transporter Conformation and Cocaine Binding J. Biol. Chem., January 30, 2004; 279(5): 3228 - 3238. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Henry, E. M. Adkins, Q. Han, and R. D. Blakely Serotonin and Cocaine-sensitive Inactivation of Human Serotonin Transporters by Methanethiosulfonates Targeted to Transmembrane Domain I J. Biol. Chem., September 26, 2003; 278(39): 37052 - 37063. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lin, P.-W. Zhang, X. Zhu, J.-M. Melgari, R. Huff, R. L. Spieldoch, and G. R. Uhl Phosphatidylinositol 3-Kinase, Protein Kinase C, and MEK1/2 Kinase Regulation of Dopamine Transporters (DAT) Require N-terminal DAT Phosphoacceptor Sites J. Biol. Chem., May 23, 2003; 278(22): 20162 - 20170. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu and H. H. Gu Cocaine Affinity Decreased by Mutations of Aromatic Residue Phenylalanine 105 in the Transmembrane Domain 2 of Dopamine Transporter Mol. Pharmacol., March 1, 2003; 63(3): 653 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lin and G. R. Uhl Dopamine Transporter Mutants with Cocaine Resistance and Normal Dopamine Uptake Provide Targets for Cocaine Antagonism Mol. Pharmacol., April 1, 2002; 61(4): 885 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Vaughan, J. D. Gaffaney, J. R. Lever, M. E. A. Reith, and A. K. Dutta Dual Incorporation of Photoaffinity Ligands on Dopamine Transporters Implicates Proximity of Labeled Domains Mol. Pharmacol., April 16, 2001; 59(5): 1157 - 1164. [Abstract] [Full Text] |
||||
![]() |
Z. Lin, W. Wang, and G. R. Uhl Dopamine Transporter Tryptophan Mutants Highlight Candidate Dopamine- and Cocaine-Selective Domains Mol. Pharmacol., April 13, 2001; 58(6): 1581 - 1592. [Abstract] [Full Text] |
||||
![]() |
S. G. F. Rasmussen, F. I. Carroll, M. J. Maresch, A. D. Jensen, C. G. Tate, and U. Gether Biophysical Characterization of the Cocaine Binding Pocket in the Serotonin Transporter Using a Fluorescent Cocaine Analogue as a Molecular Reporter J. Biol. Chem., February 9, 2001; 276(7): 4717 - 4723. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kamdar, K. M. Y. Penado, G. Rudnick, and M. M. Stephan Functional Role of Critical Stripe Residues in Transmembrane Span 7 of the Serotonin Transporter. EFFECTS OF Na+, Li+, AND METHANETHIOSULFONATE REAGENTS J. Biol. Chem., February 2, 2001; 276(6): 4038 - 4045. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |